RESOURCE / PUBLIC SOURCE RECORD
Join Team Norway at NLS Days 2026
- Event ran 8–9 September 2026 in Stockholm, Sweden; the page is marked ended. Organisers: Innovation Norway and Oslo Cancer Cluster. Partners: The Life Science Cluster, Inven2, Norwegian Pharmaceutical Industry (LMI) and Igaidi. Tagged industry: health and life science. Contacts: Rasmus Malmborg (rasmus.malmborg@innovasjonnorge.no) and Dave Tippett (dt@oslocancercluster.no).
- The page presents NLSDays as a Nordic life-science partnering event. It cites 2025 figures: 1,400+ delegates from 30 countries, 150+ onsite investors (40% from outside the Nordics), 130+ exhibitors, 80+ sponsors/partners and 120+ speakers. It highlights structured one-to-one partnering, pharma/biotech business development, investor and international-delegation attendance, keynotes, investor panels and focused exhibit-hall footfall.
- Team Norway Pavilion benefits listed: equipped branded stand, exhibitor passes by package, pavilion branding, online catalogue listing, lead capture via NLSDays platform, conference/networking/receptions, exclusive pre-event reception with Norwegian Embassy in Stockholm, and hands-on pre-event coordination from Oslo Cancer Cluster with Innovation Norway. Platinum, Gold and Silver partner options were named, but prices/package breakdown were not visible in the reviewed content.
- Exhibitor panel links include Thelper, Lytix Biopharma, two generic Business Norway company-page links, DoMore Diagnostics and Tribune Therapeutics. ESG/responsible-business, UN Guiding Principles, OECD guidance and due-diligence conditions applied.